Subclinical anthracycline cardiotoxicity in patients with acute promyelocytic leukemia in long-term remission after the aida protocol

Congestive Heart Failure, 05/03/2012

Cardiac toxicity due to anthracycline therapy is often frequent. Changes in diastolic function are helpful in the detection of subclinical anthracycline cardiotoxicity in long–term cardiac follow–up despite a preserved systolic ventricular function.

Print Article Summary Cat 2 CME Report